Puma Biotech (PBYI) Reports Q3 EPS of $0.17

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.17, versus ($1.36) reported last year. Revenue for the quarter came in at $62.6 million versus the consensus estimate of $57.94 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'